Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 20% ± 3% | |
astrocyte | 3 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of MLYCD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1679.80 | 328 / 328 | 100% | 3.27 | 178 / 178 |
prostate | 100% | 1349.93 | 245 / 245 | 99% | 4.14 | 499 / 502 |
kidney | 100% | 1317.72 | 89 / 89 | 99% | 7.09 | 895 / 901 |
thymus | 100% | 1294.47 | 652 / 653 | 99% | 3.55 | 596 / 605 |
liver | 100% | 2378.97 | 226 / 226 | 98% | 4.38 | 399 / 406 |
intestine | 100% | 1656.19 | 964 / 966 | 98% | 3.66 | 518 / 527 |
bladder | 100% | 1684.90 | 21 / 21 | 98% | 3.18 | 493 / 504 |
breast | 100% | 1497.76 | 459 / 459 | 98% | 2.69 | 1091 / 1118 |
brain | 98% | 884.08 | 2583 / 2642 | 99% | 3.60 | 700 / 705 |
skin | 99% | 859.86 | 1793 / 1809 | 97% | 3.74 | 459 / 472 |
esophagus | 99% | 1705.61 | 1431 / 1445 | 97% | 2.23 | 177 / 183 |
adrenal gland | 100% | 2284.82 | 258 / 258 | 95% | 3.87 | 219 / 230 |
stomach | 100% | 1710.94 | 359 / 359 | 95% | 3.25 | 272 / 286 |
uterus | 100% | 1313.65 | 170 / 170 | 95% | 2.41 | 435 / 459 |
ovary | 100% | 1461.02 | 180 / 180 | 92% | 2.22 | 395 / 430 |
lung | 93% | 998.73 | 538 / 578 | 97% | 2.70 | 1126 / 1155 |
adipose | 100% | 1632.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1088.42 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.49 | 1 / 1 |
muscle | 100% | 4894.49 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1448.56 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 6084.23 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 4.41 | 78 / 80 |
lymph node | 0% | 0 | 0 / 0 | 97% | 3.09 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 2.00 | 43 / 45 |
peripheral blood | 60% | 451.48 | 555 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0019395 | Biological process | fatty acid oxidation |
GO_0031998 | Biological process | regulation of fatty acid beta-oxidation |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0002931 | Biological process | response to ischemia |
GO_0006085 | Biological process | acetyl-CoA biosynthetic process |
GO_2001294 | Biological process | malonyl-CoA catabolic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0046321 | Biological process | positive regulation of fatty acid oxidation |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0050080 | Molecular function | malonyl-CoA decarboxylase activity |
GO_0042802 | Molecular function | identical protein binding |
Gene name | MLYCD |
Protein name | Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9) Malonyl-CoA decarboxylase |
Synonyms | |
Description | FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus assures that methyl-malonyl-CoA is the only chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. In peroxisomes it may be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a role in the metabolic balance between glucose and lipid oxidation in muscle independent of alterations in insulin signaling. May play a role in controlling the extent of ischemic injury by promoting glucose oxidation. . |
Accessions | ENST00000566309.2 ENST00000563312.5 ENST00000561562.5 V9GYW3 A0A087X1B8 ENST00000262430.6 [O95822-1] O95822 V9GY18 |